Adaptimmune Therapeutics PLC Sponsored ADR SEC filings and other documents
Description
Event date
Documents and forms
2025
Q2 2025
Aug 13, 2025
Earnings release8-K
Quarterly report10-Q
Q1 2025
May 13, 2025
Earnings release8-K
Quarterly report10-Q
Transcript
2024
Q4 2024
Mar 20, 2025
Annual report10-K
Earnings release8-K
Transcript
Q3 2024
Nov 13, 2024
Earnings release8-K
Quarterly report10-Q
Q2 2024
Aug 12, 2024
Earnings release8-K
Quarterly report10-Q
FDA Announcement
Aug 2, 2024
Press release
Slides
Collaboration
May 31, 2024
Press release
Q1 2024
May 15, 2024
Earnings release8-K
Quarterly report10-Q
2023
Q4 2023
Mar 6, 2024
Annual report10-K
Earnings release8-K
Q3 2023
Nov 8, 2023
Earnings release8-K
Quarterly report10-Q
Q2 2023
Aug 9, 2023
Earnings release8-K
Quarterly report10-Q
Q1 2023
May 12, 2023
Earnings release8-K
Quarterly report10-Q
2022
Q4 2022
Mar 6, 2023
Annual report10-K
Earnings release8-K
Q3 2022
Nov 8, 2022
Earnings release8-K
Quarterly report10-Q
Q2 2022
Aug 4, 2022
Earnings release8-K
Quarterly report10-Q
Q1 2022
May 9, 2022
Earnings release8-K
Quarterly report10-Q
2021
Q4 2021
Mar 14, 2022
Annual report10-K
Earnings release8-K
Q3 2021
Nov 4, 2021
Earnings release8-K
Quarterly report10-Q
Q2 2021
Aug 9, 2021
Earnings release8-K
Quarterly report10-Q
Q1 2021
May 6, 2021
Earnings release8-K
Quarterly report10-Q
2020
Q4 2020
Feb 25, 2021
Annual report10-K
2019
Q4 2019
Feb 27, 2020
Annual report10-K
2018
Q4 2018
Feb 27, 2019
Annual report10-K
2017
Q4 2017
Mar 15, 2018
Annual report10-K
2016
Q4 2016
Mar 13, 2017
Annual report10-K